advertisement
Pharmaceutics 11
Showing records 1 to 11 | Display all abstracts in Pharmaceutics92748 Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal Degeneration
Garcia-Herranz D
Pharmaceutics 2021; 13:
92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
Abdelmonem R
Pharmaceutics 2021; 13:
92748 Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal Degeneration
Rodrigo MJ
Pharmaceutics 2021; 13:
92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
Elhabal SF
Pharmaceutics 2021; 13:
92748 Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal Degeneration
Rodrigo MJ; Subias M; Subias M
Pharmaceutics 2021; 13:
92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
Abdelmalak NS
Pharmaceutics 2021; 13:
92748 Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal Degeneration
Martinez-Rincon T; Martinez-Rincon T
Pharmaceutics 2021; 13:
92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
El-Nabarawi MA
Pharmaceutics 2021; 13:
92748 Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal Degeneration
Mendez-Martinez S
Pharmaceutics 2021; 13:
92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
Teaima MH
Pharmaceutics 2021; 13:
92748 Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal Degeneration
Mendez-Martinez S; Bravo-Osuna I; Bonet A; Ruberte J; Garcia-Feijoo J; Pablo L; Garcia-Martin E; Herrero-Vanrell R
Pharmaceutics 2021; 13:
